Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
BIJON medica, UAB
Composition
Zolmitriptanum 2,5 mg
ATC Code
N02CC03
Source
URPL · 247/21
11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. Zolmitriptan is a white to almost white powder that is readily soluble in water. ZOLMITRIPTAN NASAL SPRAY is supplied as a clear to pale yellow solution of zolmitriptan, buffered to a pH 5.0. Each ZOLMITRIPTAN NASAL SPRAY contains 2.5 mg or 5 mg of zolmitriptan in a 100-μL unit dose aqueous buffered solution containing citric acid, anhydrous, USP, disodium phosphate dodecahydrate USP and purified water USP. ZOLMITRIPTAN NASAL SPRAY is hypertonic. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol. Chemical Structure
⚠️ Warnings
• Avoid taking this medication along with monoamine oxidase inhibitors to prevent allergic reactions.
• It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
• Caution should be exercised in patients with history of heart disease, menopause, poor blood supply, ischemic bowel disease, liver or kidney disease, breathing problem, high blood pressure, diabetes, stroke, during pregnancy and breastfeeding.
Patient may develop with increased risk of Serotonin Syndrome with the following symptoms: increased heart rate, shivering, sweating, dilated pupils,etc . If it is so consult with your healthcare provider.
